APPLETON, Wis. -- A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. From birth, Cole Schmidtknecht ...
(Reuters) - GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once ...
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma, a ...
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and UnitedHealth Group’s pharmacy benefit manager after they said the price for his ...
LONDON, Nov 16 (Reuters) - Inhaled drugs specialist Vectura sought to bolster confidence in the potential for a generic rival to Glaxo's lung drug Advair in Europe on Tuesday as its partner Sandoz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results